A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer
- 8 April 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (14), 2335-2341
- https://doi.org/10.1038/sj.onc.1202540
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 14 references indexed in Scilit:
- Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinomaProceedings of the National Academy of Sciences, 1998
- hMLH1 expression and cellular responses of ovarian tumour cells to treatment with cytotoxic anticancer agentsOncogene, 1997
- Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patientsNature Medicine, 1996
- Ovarian cancer, from the laboratory to the clinic: Challenges for the futureAnnals of Oncology, 1996
- Microsatellite instability and alterations in the HMSH2 gene in human ovarian cancerInternational Journal of Cancer, 1995
- Microsatellite instability in ovarian neoplasmsBritish Journal of Cancer, 1995
- Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instabilityNature Genetics, 1995
- Microsatellite instability in inherited and sporadic neoplasmsCurrent Opinion in Oncology, 1995
- Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancerNature, 1994
- Clues to the Pathogenesis of Familial Colorectal CancerScience, 1993